US 2013/0295196 A1Published application

Lauflumide and the enantiomers thereof, method for preparing same and therapeutic uses thereof

AssigneeAssistance Publique-Hopitaux de Paris

InventorEric Konofal

Life of this patent

Estimating the term…

Abstract

The invention relates to the molecule having formula (I), as well as the enantiomers thereof, and to the use of same in the treatment of ADHD, narcolepsy or idiopathic hypersomnia.

Claims14

Dependent claims

A molecule of the following formula (I):

and the enantiomers thereof.

Dependencies are inferred from the claim text.

Facts

Application: 13/980,708Filed 20 Jan 2012
Priority: FR 115045520 Jan 2011
Published: 7 Nov 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/165
Amides, e.g. hydroxamic acids: having aromatic rings, e.g. colchicine, atenolol, progabide
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/20
Medicinal preparations characterised by special physical form: pills, tablets, discs, rods
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…

Family

US 9,637,447 B2Related patent
US 2013/0295196 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results